Navigation Links
Evanston Northwestern Healthcare Researchers Explain Effects of Large-Scale, Universal MRSA Surveillance Program That Supports Expanded Intervention

March 18th publication in prominent peer-reviewed journal highlights findings of program to reduce rate of drug-resistant staph infection

EVANSTON, Ill., March 17 /PRNewswire-USNewswire/ -- Universal hospital surveillance of methicillin-resistant Staphylococcus aureus (MRSA) using a rapid molecular diagnostic test is effective in significantly reducing MRSA disease, according to research published in the Annals of Internal Medicine by a team of Evanston Northwestern Healthcare (ENH) researchers. The ENH study, "Universal Surveillance for [MRSA] in 3 Affiliated Hospitals," appears in the March 18, 2008 issue of the American College of Physicians flagship journal.

Evanston Northwestern Healthcare became the first healthcare provider in the United States to launch a comprehensive, universal MRSA surveillance program, swabbing all in-patients at its three hospitals (Evanston, Glenbrook and Highland Park) for the MRSA bacteria, a potentially fatal infection that does not respond to common antibiotics and is a significant cause of hospital-acquired infections.

"The goal of the program was always to reduce the risk of MRSA infection to patients cared for by ENH. We achieved all our benchmarks by the end of the program's first year," said Lance R. Peterson, MD, FASCP, Epidemiologist and a founder of the MRSA program at Evanston Northwestern Healthcare. "The program we began in August of 2005 had a major patient safety impact for all our patients and demonstrated that a comprehensive effort to reduce MRSA infection can be accomplished in the United States."

At its three hospitals, ENH was able to reduce MRSA infection rates by 70% in less than two years. ENH also demonstrated a system-wide compliance with admission testing of more than 90%. The program lowered the risk of other patients and staff becoming carriers of MRSA; and becoming a MRSA carrier is the highest risk for eventually developing an infection with this bacteria.

Using a new molecular screening test that was approved for patient use shortly

before the program began facilitated the ENH initiative. This test shortens the testing time for finding MRSA to under two hours and permits the detection of MRSA carriers the day of admission so that they could be appropriately cared for to reduce spread to others. Dr. Peterson stated that, "Reducing spread of MRSA to new patients within the healthcare system is critical to eliminating this infection and the ENH program encompassing over 70,000 patients shows that such a patient-oriented program can be successful."

ENH researchers defined MRSA infection as a combination of all MRSA blood-stream, respiratory, urinary tract, and surgical site infections that occurred during admission and 30 days after discharge. The study concluded that universal screening was associated with a large reduction in MRSA disease during those time frames.

The study examined the effect of two expanded MRSA surveillance interventions. It compared MRSA rates during and after hospital admission in three consecutive periods: baseline (12 months), MRSA surveillance for all admissions to the intensive care unit (12 months), and universal MRSA surveillance for all hospital admissions (21 months). Only universal surveillance was successful in significantly reducing healthcare-associated MRSA infections.

The screening program involved performing nasal swabs on all inpatients for colonization during the hospital admission process. Electronic medical record and same-day molecular diagnostic testing facilitated quick assessment for MRSA colonization and allowed hospital staff to promptly identify, isolate and treat MRSA-positive patients.

Peterson says, "Our program has successfully prevented nasal colonization of patients coming to ENH for their care. We want people to come here for their healthcare and not go home with something unexpected that will later cause an infection -- and the program is successful in doing just that."

About Evanston Northwestern Healthcare

Located in Chicago's northern suburbs, Evanston Northwestern Healthcare (ENH) is an integrated healthcare system that includes Evanston, Glenbrook and Highland Park Hospitals, ENH Medical Group (comprising 65 medical offices and facilities), ENH Home Services, ENH Research Institute and ENH Foundation.

Through its affiliation with Northwestern University's Feinberg School of Medicine, ENH supports extensive medical education and research. ENH is in the top five percent of all institutions that receive funding from the National Institutes of Health; among multi-specialty independent research hospitals, it ranks 9th in the nation.

ENH is ranked among the top 50 hospitals in the country by U.S. News & World Report.

SOURCE Evanston Northwestern Healthcare
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Northwestern Memorial Transplant Program Initiates New Study
2. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
3. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. ViroPharma to Present at Three Upcoming Healthcare Conferences
7. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
8. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
9. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
10. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
11. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... , Nov. 25, 2015  Today AVACEN Medical announced the issue of United ... Energy Including Blood Viscosity Adjustment ". This patent shields the company,s AVACEN 100 dry heat therapy ... Method. Photo - ... ... ...
(Date:11/25/2015)... Endo International plc (NASDAQ: ENDP ) (TSX: ENL) today ... will discuss corporate updates at the 27 th Annual ... on Wednesday, December 2, 2015 at 1 p.m. ET. ... then the link to the event. Participants should allow approximately ... the site and download any streaming media software needed to ...
(Date:11/25/2015)... NEW YORK , November 25, 2015 ... global market of self-monitoring blood glucose devices was valued ... to grow with a CAGR of 5.7% during 2015 ... increasing geriatric population and increasing prevalence of diabetes. In ... about diabetes care is also contributing to the growth ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... As ... Water For Empowerment ™ attracts volunteers together who want to combine talents and ... as key stakeholders in the process. The non-profit launched its first major fundraiser ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director at the Ageless ... treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for safety and efficacy, ... without the need for surgery, prescription pills, or topical foams. , “Capillus272™ Pro ...
(Date:11/25/2015)... ... November 25, 2015 , ... Lakeview Health, a Jacksonville-based drug ... their sobriety and show through pictures what a positive difference it makes. The ... with the hashtag #FacesOfGratitude on their Facebook, Twitter, and Instagram accounts. Short ...
(Date:11/25/2015)... ... ... On November 23rd 2015 Cozy Products, a division of Bird-X ... Products explains what this means for business moving forward. , The Tri Lite heater ... model: to sell personal heaters that reduce energy consumption, are economical and keep people ...
(Date:11/25/2015)... ... 2015 , ... In an ongoing Clinical Study conducted by an independent physician, ... Angel is evaluating the efficacy of its product and its disinfection protocol. This study ... from May 2014 through October 2015 at a 360-bed, acute-care, academic medical center located ...
Breaking Medicine News(10 mins):